Novel Detagging process allows Fluorous Solid Phase Extraction

06-10-2008: Veronique Gouverneur and colleagues from the University of Oxford and AstraZeneca, Cheshire, have developed a novel tagging-detagging strategy. This could be extremely useful for the purification of known and novel 18F-radiotracers for Positron Emission Tomography. It is the first detagging process to rely on a C-F bond forming event and they have shown its feasibility. To do this they synthesised fluorous allylsilanes by cross metathesis and then fluorinated them via an electrophilic substitution, using Selectfluor as the detagging reagent. Using this new method, both the fluorination and the detagging occur in the last step of the sequence. The F-target can therefore be separated from the precursor using FSPE (fluorous solid phase extraction), dramatically reducing the time required to produce the pure final product.

Their next goal will be to demonstrate that this chemistry can be done "hot", with the synthesis of known radiotracers; 'We envisage this work extending to a wider range of possible fluorodetagging strategies' Gouverneur states. 'The challenge will be to further expand the usefulness of fluorous chemistry in the context of radiochemistry.'

Original publication: Véronique Gouverneur et al., Chem. Commun., 2008.

Facts, background information, dossiers
  • positron emission tomog…
  • Fluorination
  • Electrophilic substitution
  • Cross Metathesis
  • AstraZeneca
More about Royal Society of Chemistry
Contact
Royal Society of Chemistry (RSC)
Milton Road
CB4 0WF Cambridge
GROßBRITANNIEN
Phone
+441223420066
Fax
+441223423623
  • News

    Materials: The first graphene-based chiral sensor

    A reusable, natural and cheap amylose-functionalised graphene sensor was developed for highly sensitive and visual fluorescent chiral sensing by a team in China.The team found that the sensor’s detection sensitivity toward L-tryptophan was over 100 times higher than that of recently reporte ... more

    Non-invasive tool to diagnose endometriosis

    British scientists have used infrared spectroscopy to identify biochemical differences between endometrial tissue growing outside the uterus (ectopic) and the endometrial tissue of the uterus (eutopic). They also compared the results with tissue from endometriosis-free women (benign eut ... more

    Sensor to search for artery hardening compounds in blood

    A water-soluble zinc-based fluorescent sensor to detect pyrophosphate in blood has been developed by scientists from China. Pyrophosphate plays an important role in metabolic processes in the body but a lack of the compound can lead to Mönckeberg’s arteriosclerosis – calcium deposits in art ... more

More about University of Oxford
Contact
University of Oxford
Wellington Square
OX1 2JD Oxford
GROßBRITANNIEN
  • News

    Miniature X-ray source using wiggling electrons

    A team at the Laboratory for Attosecond Physics of Ludwig Maximilian's University of Munich and Max Planck Institute of Quantum Optics in Garching has succeeded in reducing X-ray sources of typically several kilometres in size to the dimensions of a dining table. This involved a new method ... more

    New discovery may lead to new class of allergy drugs

    If you've ever wondered why some allergic reactions progress quickly and may even become fatal, a new research report published in the Journal of Leukocyte Biology provides an important part of the answer. In the report, scientists from Queen's University of Belfast, University of Oxford an ... more

    Tagging-detagging for purification of radiotracers

    Veronique Gouverneur and colleagues from the University of Oxford and AstraZeneca, Cheshire, have developed a novel tagging-detagging strategy. This could be extremely useful for the purification of known and novel 18F-radiotracers for Positron Emission Tomography. It is the first detagging ... more

More about AstraZeneca
  • News

    Thermo Fisher Scientific named a Microsoft Pharmaceutical and Life Sciences Innovation Award winner for Informatics Solutions

    Thermo Fisher Scientific announced that it is the winner of a Microsoft Corporation 2008 Pharmaceutical and Life Sciences Innovation Award in the Discovery and Product Innovation category. The award honors best-in-class companies that have made the most innovative use of Microsoft-based sol ... more

    Tagging-detagging for purification of radiotracers

    Veronique Gouverneur and colleagues from the University of Oxford and AstraZeneca, Cheshire, have developed a novel tagging-detagging strategy. This could be extremely useful for the purification of known and novel 18F-radiotracers for Positron Emission Tomography. It is the first detagging ... more

    Out of REACH

    Europe's proposed new chemicals legislation, REACH, could disrupt the supply of important medicines. David Vosvenieks, REACH issue manager at AstraZeneca (AZ), told Chemistry & Industry that two companies supplying intermediates required for two AZ drugs - one of them an anticancer therapy ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE